IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8889718 B1

PDFFull Text
Date of Patent:
Nov. 18, 2014

Filed:

Mar. 14, 2013

Thiazole derivatives

Applicant:

Kyowa Hakko Kirin Co., Ltd., Tokyo, JP;

Inventors:

Takao Nakajima, Fujisawa, JP;

Masamori Sugawara, Mishima, JP;

Shin-ichi Uchida, Sunto-gun, JP;

Tetsuji Ohno, Sunto-gun, JP;

Yuji Nomoto, Sunto-gun, JP;

Noriaki Uesaka, Sunto-gun, JP;

Yoshisuke Nakasato, Susono, JP;

Assignee:

Kyowa Hakko Kirin Co., Ltd., Tokyo, JP;

Attorney:

Fitzpatrick, Cella, Harper & Scinto

Primary Examiner:

Laura L Stockton

Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/506 (2006.01); A61K 31/4436 (2006.01); A61K 31/427 (2006.01); A61K 31/444 (2006.01); A61K 31/4725 (2006.01); A61K 31/496 (2006.01); A61K 31/5383 (2006.01); C07D 417/04 (2006.01); A61K 31/454 (2006.01); A61K 31/542 (2006.01); C07D 417/14 (2006.01); C07D 491/048 (2006.01); A61K 31/551 (2006.01); A61K 31/4439 (2006.01); A61K 31/4985 (2006.01); A61K 31/695 (2006.01); A61K 31/438 (2006.01); A61K 31/497 (2006.01); A61K 31/553 (2006.01); C07D 417/06 (2006.01); C07D 491/10 (2006.01); A61K 31/541 (2006.01); C07D 498/04 (2006.01); A61K 31/501 (2006.01); C07D 513/04 (2006.01);
U.S. Cl.
CPC ...
C07D 417/06 (2013.01); A61K 31/444 (2013.01); A61K 31/4725 (2013.01); A61K 31/427 (2013.01); A61K 31/496 (2013.01); A61K 31/5383 (2013.01); C07D 417/04 (2013.01); A61K 31/454 (2013.01); A61K 31/542 (2013.01); C07D 417/14 (2013.01); C07D 491/048 (2013.01); A61K 31/551 (2013.01); A61K 31/4439 (2013.01); A61K 31/4985 (2013.01); A61K 31/695 (2013.01); A61K 31/438 (2013.01); A61K 31/497 (2013.01); A61K 31/553 (2013.01); A61K 31/506 (2013.01); C07D 491/10 (2013.01); A61K 31/541 (2013.01); C07D 498/04 (2013.01); A61K 31/501 (2013.01); C07D 513/04 (2013.01);
Abstract

Method of treating central nervous systems disease by administering wherein n is an integer of from 0 to 3; Ris a 5-membered aromatic heterocyclic group containing at least one oxygen atom; Ris —COR(wherein Ris aryl); Ris hydrogen or lower alkyl; and Rrepresents cycloalkyl, aryl, aralkyl, alicyclic heterocyclic group, aromatic heterocyclic group, alicyclic hetocyclic-alkyl, or aromatic heterocyclic-alkyl, and R, R, Rand Rare individually optionally substituted.

Find Patent Forward Citations

Loading…